Open AccessToxicity profile of the new compound XC221GI from pre-clinical studies
Author(s) -
Svetlana A. Suhanova,
Oksana V. Proskurina,
E. A. Jain,
А. А. Глобенко,
M. I. Bagaeva,
Anastasia V. Rydlovskaya,
Vladimir E. Nebolsin
Publication year - 2022
Publication title -
epidemiology and infectious diseases
Language(s) - English
Resource type - Journals
eISSN - 2411-3026
pISSN - 1560-9529
DOI - 10.17816/eid108910
Subject(s) - inflammation , adverse effect , cytokine , toxicity , medicine , pharmacology , cytokine storm , chemokine , no observed adverse effect level , immunology , covid-19 , disease , infectious disease (medical specialty)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom